Summary of Panel Discussions

Summary of Panel Discussions

Introduction During the Workshop "Pharmacokinetics: Defining the Dose for Risk Assessment," two panel discussions were held. The first was "Design of Studies to Obtain Pharmacokinetic Data for Risk Assessment." Emil Pfitzer of HoffmannLa Roche, Inc.; James Stevens of Ciba-Geigy Corporation;Penelope FennerCrisp of the U.S. Environmental Protection Agency Pesticides Program; and Daniel Menzel of ...

Summary of Discussions

Summary of Discussions

Summary of Discussions

Summary of Discussions

It was suggested that the enhanced incorporation of choline into phospholipids in the very first stages of renal compensatory hypertrophy might result in a change of membrane fatty acid composition and of membrane fluidity (S. Solomon). L. M. Lowenstein stated that no data on fatty acid composition of kidneys undergoing compensatory hypertrophy were available. Since ligation of the ureter of th...